Back to Search
Start Over
PCN325 Health Utility in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR-DLBCL) Patients - Results of a Phase II Trial with ORAL Selinexor
- Source :
- Value in Health. 23:S479-S480
- Publication Year :
- 2020
- Publisher :
- Elsevier BV, 2020.
Details
- ISSN :
- 10983015
- Volume :
- 23
- Database :
- OpenAIRE
- Journal :
- Value in Health
- Accession number :
- edsair.doi...........655a7f08eab86129d41edbbf7897d3a6
- Full Text :
- https://doi.org/10.1016/j.jval.2020.08.462